These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients. Weizman A; Carmi M; Hermesh H; Shahar A; Apter A; Tyano S; Rehavi M Am J Psychiatry; 1986 Mar; 143(3):335-9. PubMed ID: 3006522 [TBL] [Abstract][Full Text] [Related]
27. Circannual variations in the density of tritiated imipramine binding sites on blood platelets in man. Egrise D; Desmedt D; Schoutens A; Mendlewicz J Neuropsychobiology; 1983; 10(2-3):101-2. PubMed ID: 6325993 [TBL] [Abstract][Full Text] [Related]
28. Demonstration of an imipramine endacoid in rat brain. Rehavi M; Ventura I; Sarne Y Prog Clin Biol Res; 1985; 192():465-72. PubMed ID: 3001767 [TBL] [Abstract][Full Text] [Related]
29. Human plasma inhibitors of platelet serotonin uptake and imipramine receptor binding: extraction and heterogeneity. Brusov OS; Fomenko AM; Katasonov AB Biol Psychiatry; 1985 Mar; 20(3):235-44. PubMed ID: 2983787 [TBL] [Abstract][Full Text] [Related]
30. Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients. Wood PL; Suranyi-Cadotte BE; Nair NP; LaFaille F; Schwartz G Neuropharmacology; 1983 Oct; 22(10):1211-4. PubMed ID: 6316192 [TBL] [Abstract][Full Text] [Related]
31. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum. Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766 [TBL] [Abstract][Full Text] [Related]
32. Amitriptylinoxide: receptor-binding profile compared with other antidepressant drugs. Borbe HO; Zierenberg O Pharmacopsychiatry; 1985 Sep; 18(5):314-9. PubMed ID: 2996040 [TBL] [Abstract][Full Text] [Related]
38. WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative Study. Bech P; Eplov L; Gastpar M; Gentsch C; Mendlewicz J; Plenge P; Rielaert C; Mellerup ET Pharmacopsychiatry; 1988 May; 21(3):147-50. PubMed ID: 2841696 [No Abstract] [Full Text] [Related]
39. Diurnal and circannual variation in platelet 3H-imipramine binding: comparative data on normal and affectively ill subjects. Baron M; Barkai A; Kowalik S; Fieve RR; Quitkin F; Gruen R Neuropsychobiology; 1988; 19(1):9-11. PubMed ID: 2847077 [TBL] [Abstract][Full Text] [Related]
40. Changes in platelet 3H-imipramine binding in depressed patients receiving electroconvulsive therapy. Maj M; Mastronardi P; Cerreta A; Romano M; Mazzarella B; Kemali D Biol Psychiatry; 1988 Aug; 24(4):469-72. PubMed ID: 2841987 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]